Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination.
Kirby L, Jin J, Cardona JG, Smith MD, Martin KA, Wang J, Strasburger H, Herbst L, Alexis M, Karnell J, Davidson T, Dutta R, Goverman J, Bergles D, Calabresi PA. · 2019
Read Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination. by Kirby L, Jin J, Cardona JG, Smith MD, Martin KA, Wang J, Strasburger H, Herbst L, Alexis M, Karnell J, Davidson T, Dutta R, Goverman J, Bergles D, Calabresi PA. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6715717.txt.
Introduction
Kirby and co-authors studied oligodendrocyte precursor cells in inflammatory brain disease. These precursor cells, called OPCs, can rebuild the myelin insulation that nerve fibers lose. In multiple sclerosis that repair often falls short. The team traced OPCs in a mouse model of inflammatory demyelination.
They found that T cells and the signal molecule IFN-gamma block OPCs from maturing. IFN-gamma also cuts OPC numbers and arms the survivors to show antigens to killer T cells, which then kill them. Human MS lesions showed the same immune gear switched on. Blocking this immune activation of OPCs might help repair.
Catalog record
| CREATOR | Kirby L, Jin J, Cardona JG, Smith MD, Martin KA, Wang J, Strasburger H, Herbst L, Alexis M, Karnell J, Davidson T, Dutta R, Goverman J, Bergles D, Calabresi PA. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 88 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination By Leslie Kirby, Jing Jin, Jaime Gonzalez Cardona, Matthew D. Smith, Kyle A. Martin, Jingya Wang, Hayley Strasburger, Leyla Herbst, Maya Alexis, Jodi Karnell, Todd Davidson, Ranjan Dutta Published in: Nature Communications DOI: 10.1038/s41467-019-11638-3 ABSTRACT Oligodendrocyte precursor cells (OPCs) are abundant in the adult central nervous system, and have the capacity to regenerate oligodendrocytes and myelin. However, in inflammatory diseases such as multiple sclerosis (MS) remyelination is often incomplete. To investigate how neuroinflammation influences OPCs, we perform in vivo fate-tracing in an inflammatory demyelinating mouse model. Here we report that OPC differentiation is inhibited by both effector T cells and IFNγ overexpression by astrocytes. IFNγ also reduces the absolute number of OPCs and alters remaining OPCs by inducing the immunoproteasome and MHC class I. In vitro, OPCs exposed to IFNγ cross-present antigen to cytotoxic CD8 T cells, resulting in OPC death. In human demyelinated MS brain lesions, but not normal appearing white matter, oligodendroglia exhibit enhanced expression of the immunoproteasome subunit PSMB8. Therefore, OPCs may be co-opted by the immune system in MS to perpetuate the autoimmune response, suggesting that inhibiting immune activation of OPCs may facilitate remyelination. INTRODUCTION Oligodendrocyte precursor cells (OPCs) that express the proteoglycan neuron-glial antigen 2 (NG2) are a highly dynamic, proliferative group of progenitors that remain abundant in the adult CNS. Differentiation of OPCs into oligodendrocytes allows oligodendrocyte generation to continue into adulthood for adaptive myelination and the ability to regenerate myelin following injury or disease. However, the abundance and broad coverage of NG2+ OPCs in both gray and white matter of the CNS, suggests that they may have other functions; indeed, OPCs survey their microenvironment through constant filopodia extension1–4, migrate to sites of injury and respond to inflammatory cues5–8, behaviors remarkably similar to microglial cells. The significance of these non-progenitor behaviors in both physiological and pathological conditions are not well understood. In the setting of chronic inflammatory demyelinating diseases such as multiple sclerosis (MS) the process of endogenous remyelination is inefficient, rendering axons susceptible to degeneration through loss of trophic support and direct toxic effects of immune cells. Recently, subsets of immune cells have been shown to have differing roles in response to demyelination. OPCs express cytokine receptors, and their differentiation is inhibited by interferon-gamma (IFNγ)9–14, interleukin-17 (IL-17)5,6, and high doses of tumor necrosis factor (TNF)15,16, but the mechanistic pathways mediating these effects remain incompletely understood. T regulatory cells (Treg)7 and alternatively activated monocytes (M2)17 can facilitate endogenous remyelination through direct actions on OPCs, but Tregs are known to be deficient in MS18. Whereas, CD4+ T cells of the Th1 and Th17 lineage have long been recognized to be key in the establishment and perpetuation of MS19–21. Although genetic variation in MHC class II alleles has been strongly associated with MS risk implicating CD4+ T cells, CD8+ cells outnumber CD4+ cells in MS lesions22–24. In addition, axonal damage closely correlates with CD8+ cell number prevalence rather than CD4 prevalence25. While CD4+ and CD8+ cells mediate pathology through cytokine release, the additional cytotoxic properties of CD8+ cells are likely important in the pathogenesis of MS26–31. Importantly, recruitment of OPCs to the demyelinated lesion temporally and spatially overlaps with the persistence of CD4+ and CD8+ T cells32, suggesting that OPCs may be influenced by changes in the microenvironment caused by T cells. We and others have previously used in vivo genetic fate tracing to track the differentiation of OPCs into mature myelin-producing oligodendrocytes during remyelination in the cuprizone model33,34. We demonstrated that adoptive transfer of myelin-reactive T effector cells inhibits endogenous remyelination in the corpus callosum without causing irreparable damage to the axons, as occurs in the spinal cord of animals with experimental autoimmune encephalomyelitis (EAE)35. Based on these prior studies we hypothesized that inflammatory cytokines might directly influence the properties of OPCs and inhibit their differentiation. Here, we identify a signaling pathway in OPCs that both diverts them from differentiating into mature oligodendrocytes and induces expression of antigen-presenting capacity through induction of the immunoproteasome. IFNγ conditioned OPCs highly express MHC class I molecules and present antigens to cytotoxic T cells, in vitro and in vivo. Analysis of postmortem MS tissue reveals the presence of immunoproteasome expressing Sox-10+ cells in white matter lesions, suggesting that OPCs in human disease exhibit similar phenotypic changes. Therapeutic manipulation of this pathway could facilitate functional remyelination by suppressing OPC mediated inflammation, reducing cytotoxic mediated cell death and promoting their differentiation into myelin-forming oligodendrocytes. RESULTS Effector T cells inhibit remyelination by targeting OPCs To better understand the mechanisms by which IFNγ/IL-17 dual producing T cells inhibit remyelination, we adoptively transferred (AT) myelin-reactive cytokine secreting T cells into mice following 4 weeks of 0.2% CPZ35. In vivo lineage tracing of OPCs was performed utilizing PDGFRα-CREERxRosa26-YFP mice (C57BL/6) (Supplementary Fig. 1a)33. The recombined population of OPCs mobilized to promote myelin repair was monitored during remyelination and the influence of the effector T cell transfer was quantified (Supplementary Fig. 1b–e). We analyzed the differentiation of YFP+ OPCs and myelin content at 1 and 2 weeks after AT (Fig. 1a–d, Supplementary Fig. 2a, b). We detected CD3+ cells at both time points in CPZ and non-CPZ mouse corpus callosum following AT (Fig. 1a, b, Supplementary Fig. 2a, b). Black Gold myelin staining revealed that remyelination was inhibited post AT, but T cells by themselves do not cause demyelination in non-CPZ corpora callosa (Fig. 1b, Supplementary Fig. 2b). A significant reduction in total YFP+ cells was observed at both time points in AT-CPZ mice (Fig. 1c, d). We analyzed the proportion of YFP+ oligodendrocyte lineage cells using the markers PDGFRα, and CC1. In AT-CPZ mice one week post adoptive transfer, the two populations of OPCs (YFP+/PDGFRα+/CC1−) and intermediate oligodendrocytes (YFP+/PDGFRα−/CC1−) were significantly reduced in comparison to CPZ alone (Fig. 1a, c, Supplementary Fig. 2a). The YFP+ mature oligodendrocyte population was significantly reduced in the AT-CPZ mice, as compared to CPZ alone two-weeks post AT (Fig. 1b, d, Supplementary Fig. 2b). Since it would be expected that homeostatic OPC proliferation would maintain cell numbers, an explanation for the reduced number of YFP+ cells might be that the OPCs or oligodendrocyte lineage cells were undergoing cell death specifically in AT-CPZ mice, thus retarding the homeostatic process, a hypothesis that we mechanistically pursued in subsequent experiments.Fig. 1Effector T cells inhibit remyelination by targeting OPCs. PDGFRα-CreER x Rosa26-YFP were kept on a 0.2% CPZ diet for a total of 4-weeks. 4HT injection at 3-weeks allowed for tracking of OPCs through the remyelination process. Approximately 8–10 million MOG35-55 specific T cells were injected into recipient mice at 4-weeks. a 1-week (scale bar 400 μm) and b 2-week images of Black Gold myelin staining (1st row). Representative images of the corpus callosum of brain sections (a, b 2nd row–4th row) stained with YFP/PDGFRα (a, b-2nd row) allowed tracking of recombined OPCs, stained with YFP/CC1 identified recombined mature oligodendrocytes (a, b-3rd row) and stained with CD3/MBP show the distribution of lymphocytes and myelin (a, b-4th row). c, d Quantification of 1-week (c) and 2-week (d) immunohistochemistry data to identify different stages of oligodendrocyte differentiation using the markers YFP, PDGFRα, and CC1. Oligodendrocyte lineage populations were compared between groups; No-CPZ (white; n